Serum beta 2-microglobulin in patients with non-Hodgkin's lymphoma.
Anderson, Heather Scarffe, J Howard Swindell, Ric Crowther, Derek
Anderson, Heather
Scarffe, J Howard
Swindell, Ric
Crowther, Derek
Citations
Altmetric:
Abstract
Eighty-one patients with non-Hodgkin's lymphoma had serum beta 2-microglobulin (beta 2M) estimated at presentation. A significant association was found between beta 2M levels and stage of disease (P less than 0.001), presence of hepatomegaly (P less than 0.001) and bone marrow involvement (P less than 0.05). No association was found between the level of beta 2M and histological group, presence of splenomegaly, lymph-node masses greater than 5 cm in diameter, lymphocyte count or the presence of systemic B symptoms. Pretreatment levels of beta 2M did not help predict response to treatment and achievement of a complete remission, the length of remission obtained or survival.
Description
Date
1983-03
Publisher
Collections
Keywords
Type
Article
Citation
Serum beta 2-microglobulin in patients with non-Hodgkin's lymphoma. 1983, 19 (3):327-31 Eur J Cancer Clin Oncol